Teva Pharmaceuticals USA, Inc. Recalls

2 recalls found for Teva Pharmaceuticals USA, Inc.. Check if any of your products are affected.

Health & Personal Care

HIGH

FDA DRUG

Teva Clonidine Transdermal System Recall Expands Over CGMP Deviations, 124,054 Cartons Affected (202

Teva Pharmaceuticals recalled 124,054 cartons of Clonidine Transdermal System due to CGMP deviations from an unapproved raw material. The recall affects products sold in the United States. Consumers should stop using the product immediately and consult a healthcare provider for guidance.

Mar 19, 2026

Clonidine Transdermal System

CGMP Deviations:

Health & Personal Care

HIGH

FDA DRUG

Teva Isotretinoin 40 mg Capsules Recalled for Superpotent and Subpotent Lots (D-0446-2026)

Teva Pharmaceuticals USA, Inc. recalls 8,376 isotretinoin 40 mg capsules distributed to FL, OH, PR and MS after FDA enforcement report flags superpotent and subpotent lots. Patients should stop use and contact their healthcare providers for guidance.

Jan 12, 2026

Isotretinoin

Superpotent and

Brand Statistics

Total Recalls

Pages

Teva Pharmaceuticals USA, Inc. Recalls

Teva Clonidine Transdermal System Recall Expands Over CGMP Deviations, 124,054 Cartons Affected (202

Teva Isotretinoin 40 mg Capsules Recalled for Superpotent and Subpotent Lots (D-0446-2026)

Brand Statistics

Related Brands